scholarly journals Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games

2019 ◽  
Vol 53 (17) ◽  
pp. 1105-1110 ◽  
Author(s):  
Mark Stuart ◽  
Young In Kwon ◽  
Sandy Jeong Rhie
Keyword(s):  
Expert Knowledge ◽  
Medication Use ◽  
Clinical Information ◽  
International Olympic Committee ◽  
Pharmacy Services ◽  
Length Of Treatment ◽  
The World ◽  
World Anti Doping Agency ◽  
Effective Medication ◽  
Paralympic Games

ObjectivePharmacy services at large multisport events support safe and effective medication use. Our aim is to describe the contribution of pharmacists and to share the pharmacy experiences at the 2018 PyeongChang Olympic and Paralympic Games.MethodsThe data collected included the accreditation details of patients and prescribers indicating: sport, country, athlete or non-athlete status, and prescription details including: medication, strength, frequency, length of treatment, for the period of the Olympic Games (1–26 February 2018) and the Paralympic Games (5–20 March 2018). The numbers of prescriptions dispensed were analysed by medication category, sports and country of the patient.ResultsA total of 5313 medication items were dispensed over the course of the Olympic and Paralympic Games (athletes: 670; non-athletes: 4615; unknown: 28), for a total of 2360 patients. 72 of 82 countries (87.8%) had fewer than 20 patient visits. The first high peak (Olympic: 5.0%; Paralympic: 7.3%) of daily volume of prescriptions were dispensed in the 2 days prior to the Olympic and the 1 day prior to Paralympic opening ceremonies. Therapeutic Use Exemption (TUE) and International Olympic Committee NeedlePolicy were well managed and compliant with the regulations.ConclusionPharmacy services at major multisport games include dispensing over 5000 prescriptions, supporting the TUE and IOC Needle Policy processes and providing clinical information to athletes and prescribers on drugs in sports and the World Anti-Doping Agency regulations of drugs prohibited in sport. During the PyeongChang 2018 Olympic and Paralympic Winter Games, pharmacists played a crucial role in delivering safe and effective pharmacy service based on their expert knowledge in antidoping and the clinical use of drugs in sport.

The toxic doxa of “clean sport” and IOC’s and WADA’s quest for credibility

2020 ◽  
pp. 101269022097735
Author(s):  
Fabien Ohl ◽  
Lucie Schoch ◽  
Bertrand Fincoeur
Keyword(s):  
Impression Management ◽  
International Olympic Committee ◽  
Policy Documents ◽  
Official Policy ◽  
The World ◽  
World Anti Doping Agency ◽  
Field Notes

The World Anti-Doping Agency (WADA) and the International Olympic Committee (IOC) have been held accountable for the “Russian crisis,” a major state-sponsored doping scandal, which began in 2014. The scandal has brought intense scrutiny on the IOC’s and WADA’s efficiency in curbing doping. This paper argues that their impaired credibility should not only be explained through their objective failure in preventing doping in Russia but can be mainly understood through an analysis of their staged promises of clean sport. This study relies on the analysis of a corpus of official policy documents from the IOC and WADA over the last two decades, several media sources, and field-notes from our “participant-as-observer” role during several anti-doping meetings. In the first part of this article, we argue that to convince the audiences of their commitment to the fight against doping, WADA and the IOC collaborate to create a “team presentation” in which “impression management” is used to stage promises of a strong anti-doping doxa. The second part of the article elaborates that performances are vulnerable and complicated. Because of its scale, the Russian crisis disrupted the IOC’s and WADA’s dramaturgy, revealing their individual agendas and their rivalries over the control of the doxa, with the IOC seeking to protect its power and WADA trying to remain a “trust device.” Finally, the article shows that the IOC and WADA trapped themselves within their own staged discourse because of their divisions and their outbidding promises of clean sport, which turned ineffective and even “toxic.” We conclude that such a scenario was detrimental to the overall anti-doping efforts and the subsequent credibility of these organizations.

Olympic anti-doping laboratory: the analytical technological road from 2016 Rio De Janeiro to 2021 Tokyo

Bioanalysis ◽  
2021 ◽  
Vol 13 (19) ◽  
pp. 1511-1527
Author(s):  
Khadija Saad ◽  
Sofia Salama ◽  
Peter Horvatovich ◽  
Mohammed Al Maadheed ◽  
Costas Georgakopoulos
Keyword(s):  
Rio De Janeiro ◽  
Olympic Games ◽  
International Olympic Committee ◽  
The World ◽  
Doping In Sports ◽  
World Anti Doping Agency ◽  
Accredited Laboratory ◽  
Modern Era

The summer Olympic Games is the major mega sports event since the first modern era Olympiad, held in Athens, Greece in 1896. International Olympic Committee (IOC) has the responsibility of the organization of the summer and winter Games ensuring the broadcast in all corners of earth. The World Anti-Doping Agency (WADA) is the responsible organization of the fight against doping in sports. IOC and WADA support the event's country WADA Accredited Laboratory to incorporate the maximum of the new analytical technologies to become applicable during the event's antidoping testing. The current study reviewed the last 5 years progresses of the antidoping system with emphasis on the laboratory field.

scholarly journals Plato on Natural Kinds: The Promethean Method of the Philebus

Apeiron ◽  
2021 ◽  
Vol 0 (0) ◽  
Author(s):  
John D. Proios
Keyword(s):  
Social Sciences ◽  
Natural Kind ◽  
Intelligent Design ◽  
Expert Knowledge ◽  
Natural Kinds ◽  
Natural World ◽  
History Of Philosophy ◽  
The World ◽  
History Of

Abstract Plato’s invention of the metaphor of carving the world by the joints (Phaedrus 265d–66c) gives him a privileged place in the history of natural kind theory in philosophy and science; he is often understood to present a paradigmatic but antiquated view of natural kinds as possessing eternal, immutable, necessary essences. Yet, I highlight that, as a point of distinction from contemporary views about natural kinds, Plato subscribes to an intelligent-design, teleological framework, in which the natural world is the product of craft and, as a result, is structured such that it is good for it to be that way. In Plato’s Philebus, the character Socrates introduces a method of inquiry whose articulation of natural kinds enables it to confer expert knowledge, such as literacy. My paper contributes to an understanding of Plato’s view of natural kinds by interpreting this method in light of Plato’s teleological conception of nature. I argue that a human inquirer who uses the method identifies kinds with relational essences within a system causally related to the production of some unique craft-object, such as writing. As a result, I recast Plato’s place in the history of philosophy, including Plato’s view of the relation between the kinds according to the natural and social sciences. Whereas some are inclined to separate natural from social kinds, Plato holds the unique view that all naturalness is a social feature of kinds reflecting the role of intelligent agency.

scholarly journals Development and delivery of pharmacy services for the London 2012 Olympic and Paralympic Games: Table 1

2012 ◽  
Vol 20 (1) ◽  
pp. 42-45 ◽  
Author(s):  
Mark Stuart ◽  
David Mottram ◽  
David Erskine ◽  
Stephen Simbler ◽  
Trudy Thomas
Keyword(s):  
Pharmacy Services ◽  
London 2012 ◽  
Paralympic Games

scholarly journals Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative Bacteria

2003 ◽  
Vol 47 (8) ◽  
pp. 2659-2662 ◽  
Author(s):  
John P. Ouderkirk ◽  
Jill A. Nord ◽  
Glenn S. Turett ◽  
Jay Ward Kislak
Keyword(s):  
Renal Failure ◽  
Renal Function ◽  
Renal Toxicity ◽  
Clinical Information ◽  
Polymyxin B ◽  
Gram Negative Bacteria ◽  
Gram Negative ◽  
Length Of Treatment ◽  
Baseline Renal Function ◽  
Overall Mortality

ABSTRACT Reported rates of nephrotoxicity associated with the systemic use of polymyxins have varied widely. The emergence of infections due to multiresistant gram-negative bacteria has necessitated the use of systemic polymyxin B once again for the treatment of such infections. We retrospectively investigated the rate of nephrotoxicity in patients receiving polymyxin B parenterally for the treatment of infections caused by multiresistant gram-negative bacteria from October 1999 to September 2000. Demographic and clinical information was obtained for 60 patients. Outcome measures of interest were renal toxicity and clinical and microbiologic efficacy. Renal failure developed in 14% of the patients, all of whom had normal baseline renal function. Development of renal failure was independent of the daily and cumulative doses of polymyxin B and the length of treatment but was significantly associated with older age (76 versus 59 years, P = 0.02). The overall mortality was 20%, but it increased to 57% in those who developed renal failure. The organism was cleared in 88% of the patients from whom repeat specimens were obtained. The use of polymyxin B to treat multiresistant gram-negative infections was highly effective and associated with a lower rate of nephrotoxicity than previously described.

WADA and Doping in World Sport

2017 ◽  
Author(s):  
Thomas M. Hunt
Keyword(s):  
Performance Enhancement ◽  
Governance Structure ◽  
Second World War ◽  
International Governance ◽  
The World ◽  
World Anti Doping Agency ◽  
The Subject ◽  
The 1960S ◽  
Regulatory Powers ◽  
Second World

Performance enhancement in sport has a long and controversial history. Although several organizations enacted prohibitions on the subject of doping prior to the Second World War, public scrutiny on the issue remained relatively light until the second half of the twentieth century. Beginning in the 1960s, officials passed a number of regulatory measures with the twin goals of protecting the health of athletes and ensuring the fairness of competitions. Due partially to the effects of Cold War political rivalries, the use of drugs by athletes nevertheless remained widespread in the world of sport. This policy situation changed dramatically with the end of the superpower conflict in 1991, however. The following decade was marked by increasingly vociferous calls for reform from outside the international governance structure for sport. In February of 1999, regulatory powers over the subject were centralized in a new organization called the World Anti-Doping Agency (WADA).

scholarly journals Managing compliance with the World Anti-Doping Code: China’s strategies and their implications

2018 ◽  
Vol 55 (3) ◽  
pp. 251-271 ◽  
Author(s):  
Tien-Chin Tan ◽  
Alan Bairner ◽  
Yu-Wen Chen
Keyword(s):  
Field Research ◽  
High Price ◽  
Chinese Government ◽  
Sporting Events ◽  
Winter Olympics ◽  
Fair Competition ◽  
The World ◽  
World Anti Doping Agency ◽  
The Government ◽  
One Year

With the problems of doping in sport becoming more serious, the World Anti-Doping Code was drafted by the World Anti-Doping Agency in 2003 and became effective one year later. Since its passage, the Code has been renewed four times, with the fourth and latest version promulgated in January 2015. The Code was intended to tackle the problems of doping in sports through cooperation with governments to ensure fair competition as well as the health of athletes. To understand China’s strategies for managing compliance with the Code and also the implications behind those strategies, this study borrows ideas from theories of compliance. China’s high levels of performance in sport, judged by medal success, have undoubtedly placed the country near the top of the global sports field. Therefore, how China acts in relation to international organizations, and especially how it responds to the World Anti-Doping Agency, is highly significant for the future of elite sport and for the world anti-doping regime. Through painstaking efforts, the researchers visited Beijing to conduct field research four times and interviewed a total of 22 key sports personnel, including officials at the General Administration of Sports of China, the China Anti-Doping Agency, and individual sport associations, as well as sport scholars and leading officials of China’s professional sports leagues. In response to the World Anti-Doping Agency, China developed strategies related to seven institutional factors: ‘monitoring’, ‘verification’, ‘horizontal linkages’, ‘nesting’, ‘capacity building’, ‘national concern’ and ‘institutional profile’. As for the implications, the Chinese government is willing and able to comply with the World Anti-Doping Agency Code. In other words, the Chinese government is willing to pay a high price in terms of money, manpower and material resources so that it can recover from the disgrace suffered as a result of doping scandals in the 1990s. The government wants to ensure that China’s prospects as a participant, bidder and host of mega sporting events are not compromised, especially as the host of the 2022 Winter Olympics in Beijing.

scholarly journals Can a Person with Attention Deficit Hyperactivity Disorder be an Athlete?

2017 ◽  
Vol 63 (3) ◽  
pp. 110-114
Author(s):  
Alexandru Robert Vlad ◽  
Andreea Ioana Lungu
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Elite Athlete ◽  
Neuropsychiatric Disorder ◽  
Occupational Functioning ◽  
Stimulant Drugs ◽  
Hyperactivity Disorder ◽  
The World ◽  
Adolescents And Adults ◽  
World Anti Doping Agency

AbstractAttention-deficit–hyperactivity disorder (ADHD) is a common neuropsychiatric disorder that impairs academic, social and occupational functioning in children, adolescents and adults. It is characterized by excessive activity, restlessness, and nervousness. The disease occurs in general at children before the age of 7 and usually is not easy to be detected, due to various symptoms. When the diagnosis is established the physician can prescribe two types of drugs, stimulants: amphetamine, dexamphetamine, lisdexamphetamine, methylphenidate, and non-stimulants such as: guanfacine, atomoxetine, and clonidine. So what can be done for a person who has ADHD, and wants to be an elite athlete? Due to the rules established by the World Anti-Doping Agency the stimulant drugs are prohibited in competition and if traces of a prohibited substance are detected in the sample of blood of the athlete his access to competition can be blocked from 2-4 years, from that date of the incident. Fortunately for some athletes the disease was acute in childhood but as they grew up the symptoms were reminiscent and they could concentrate at the sporting task that was supposed to be achieved. What about those athletes that still have the symptoms? Well, they can be treated with the non-stimulant drugs, but their doctor must monthly verify if the list of prohibited drugs has been changed. In conclusion we can say that ADHD can be an impediment, but with the help of parents, teachers, and physicians the athlete can achieve very good performances.

Sign in / Sign up

Export Citation Format

Share Document